DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sánchez AIP, Roces LV, García IZ. , et al.
Value of α-fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma.
Oncol Lett 2018;
15 (06) 8863-8870
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.